Lack of Funding for Direct-Acting Oral Anticoagulants for the Treatment of Pulmonary Embolism in Spain: Why and Until When

Arch Bronconeumol. 2023 Aug;59(8):471-472. doi: 10.1016/j.arbres.2023.01.015. Epub 2023 Feb 7.

[Article in English, Spanish]

Authors

María Barca-Hernando¹, Alberto García-Ortega², Luis Jara-Palomares³

Affiliations

¹ Respiratory Department, Hospital Virgen del Rocio, Sevilla, Spain.
² Servicio de Neumología, Hospital Universitario Doctor Peset, Valencia, Spain.
³ Respiratory Department, Hospital Virgen del Rocio, Sevilla, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: luisoneumo@hotmail.com.

PMID: 36803938
DOI: 10.1016/j.arbres.2023.01.015

No abstract available

Publication types

Editorial

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Factor Xa Inhibitors* / therapeutic use
Humans
Pulmonary Embolism* / drug therapy
Spain / epidemiology

Substances

Factor Xa Inhibitors
Anticoagulants